Tradewinds Capital Management, LLC Bio N Tech Se Transaction History

Tradewinds Capital Management, LLC

  • $372 Million
  • Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 117 shares of BNTX stock, worth $13,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 70 67.14%
Holding current value
$13,043
Previous $5,000 160.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$78.36 - $124.66 $3,682 - $5,859
47 Added 67.14%
117 $13,000
Q2 2024

Jul 17, 2024
BUY
$80.36 - $102.87 $5,625 - $7,200
70 New
70 $5,000

Others Institutions Holding BNTX

# of Institutions
325
Shares Held
39.2M
Call Options Held
845K
Put Options Held
1.23M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email